Intrapatient Variability (IPV) and the Blood Concentration Normalized by the Dose (C/D Ratio) of Tacrolimus-Their Correlations and Effects on Long-Term Renal Allograft Function

被引:2
作者
Kwiatkowska, Ewa [1 ]
Ciechanowski, Kazimierz [1 ]
Domanski, Leszek [1 ]
Dziedziejko, Violetta [2 ]
Przybycinski, Jaroslaw [1 ]
Pawlik, Andrzej [3 ]
机构
[1] Pomeranian Med Univ, Clin Dept Nephrol Transplantol & Internal Med, PL-70111 Szczecin, Poland
[2] Pomeranian Med Univ, Dept Biochem & Med Chem, PL-70111 Szczecin, Poland
[3] Pomeranian Med Univ, Dept Physiol, PL-70111 Szczecin, Poland
关键词
allograft function; tacrolimus; therapy; intrapatient variability; KIDNEY-TRANSPLANTATION; PATIENT VARIABILITY; UNITED-STATES; IMPACT; CLEARANCE; REJECTION; BENEFIT; FK506; LIVER;
D O I
10.3390/biomedicines10112860
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Tacrolimus, in combination with mycophenolate mofetil and glucocorticoids, is the basis of immunosuppressive therapy after renal transplantation. Tacrolimus intrapatient variability (IPV) and the blood concentration normalized by the dose (concentration/dose ratio, C/D ratio) both have an effect on the function of the transplanted kidney. In this study, we examined whether the metabolism rate affected IPV, whether the C/D ratio value was stable in the long-term follow-up, and whether it could be used for IPV measurements. In addition, our study population was examined for the effect of the C/D ratio and IPV on long-term renal function. The C/D ratio and IPV were examined in 170 patients at appointments held at 3, 6, 12 and 24 months after RTx. The average time post renal transplantation was 70 months. Renal function defined as creatinine concentration at the last appointment was examined. Results: the mean C/D ratio in the study group was 1.63. A negative correlation between the C/D ratio and creatinine concentration at the end of the follow-up was observed. Between the C/D ratio < and >= 1.63 groups, significant differences in creatinine concentration at the last appointment were found. No relationship was identified between the mean C/D ratio and IPV. The C/D ratio values increased significantly over a longer post-transplant period (12, 24, 60 and 120 m). We did not find a correlation between the mean IPV and the creatinine concentration from the last appointment. Our study group was divided into terciles according to IPV, while no renal graft function differences were found at the same appointment. Conclusion: the C/D ratio is useful for assessing the effects of the metabolism rate of tacrolimus on the long-term renal graft function. The C/D ratio does not affect the IPV value. IPV calculated from variability of the C/D ratio does not influence transplanted kidney function. The C/D changes over time.
引用
收藏
页数:10
相关论文
共 20 条
  • [1] Tacrolimus Variability: A Cause of Donor-Specific Anti-HLA Antibody Formation in Children
    Aksoy, Gulsah Kaya
    Comak, Elif
    Koyun, Mustafa
    Akbas, Halide
    Akkaya, Bahar
    Aydinli, Bulent
    Ucar, Fahri
    Akman, Sema
    [J]. EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2019, 44 (04) : 539 - 548
  • [2] High within-patient variability in the clearance of tacrolimus is a risk factor for poor long-term outcome after kidney transplantation
    Borra, Lennaert C. P.
    Roodnat, Joke I.
    Kal, Judith A.
    Mathot, Ron A. A.
    Weimar, Willem
    van Gelder, Teun
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2010, 25 (08) : 2757 - 2763
  • [3] CYP3A5*3 Genotype Associated With Intrasubject Pharmacokinetic Variation Toward Tacrolimus in Bioequivalence Study
    Chung, Jae Yong
    Lee, Yoon Jung
    Jang, Seong Bok
    Lim, Lay Ahyoung
    Park, Min Soo
    Kim, Kyung Hwan
    [J]. THERAPEUTIC DRUG MONITORING, 2010, 32 (01) : 67 - 72
  • [4] Tacrolimus Intrapatient Variability, Time in Therapeutic Range, and Risk of De Novo Donor-Specific Antibodies
    Davis, Scott
    Gralla, Jane
    Klem, Patrick
    Stites, Erik
    Wiseman, Alexander
    Cooper, James E.
    [J]. TRANSPLANTATION, 2020, 104 (04) : 881 - 887
  • [5] High tacrolimus intra-patient variability is associated with graft rejection, and de novo donor-specific antibodies occurrence after liver transplantation
    Del Bello, Arnaud
    Congy-Jolivet, Nicolas
    Danjoux, Marie
    Muscari, Fabrice
    Lavayssiere, Laurence
    Esposito, Laure
    Hebral, Anne-Laure
    Belliere, Julie
    Kamar, Nassim
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2018, 24 (16) : 1795 - 1802
  • [6] Calcineurin Inhibitor Minimization in the Symphony Study: Observational Results 3 Years after Transplantation
    Ekberg, H.
    Bernasconi, C.
    Tedesco-Silva, H.
    Vitko, S.
    Hugo, C.
    Demirbas, A.
    Reyes Acevedo, R.
    Grinyo, J.
    Frei, U.
    Vanrenterghem, Y.
    Daloze, P.
    Halloran, P. F.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 (08) : 1876 - 1885
  • [7] Impact of Subclinical Inflammation on the Development of Interstitial Fibrosis and Tubular Atrophy in Kidney Transplant Recipients
    Heilman, R. L.
    Devarapalli, Y.
    Chakkera, H. A.
    Mekeel, K. L.
    Moss, A. A.
    Mulligan, D. C.
    Mazur, M. J.
    Hamawi, K.
    Williams, J. W.
    Reddy, K. S.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 (03) : 563 - 570
  • [8] Relationship of FK506 whole blood concentrations and efficacy and toxicity after liver and kidney transplantation
    Kershner, RP
    Fitzsimmons, WE
    [J]. TRANSPLANTATION, 1996, 62 (07) : 920 - 926
  • [9] Identification of Factors Affecting Tacrolimus Level and 5-Year Clinical Outcome in Kidney Transplant Patients
    Kim, In-Wha
    Noh, Hyejin
    Ji, Eunhee
    Han, Nayoung
    Hong, Su Hyun
    Ha, Jongwon
    Burckart, Gilbert J.
    Oh, Jung Mi
    [J]. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2012, 111 (04) : 217 - 223
  • [10] Long-Term Renal Allograft Survival in the United States: A Critical Reappraisal
    Lamb, K. E.
    Lodhi, S.
    Meier-Kriesche, H. -U
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 (03) : 450 - 462